NCT05938309 A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
| NCT ID | NCT05938309 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fujian Medical University |
| Condition | Gastrointestinal Stromal Tumors |
| Study Type | OBSERVATIONAL |
| Enrollment | 194 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 194 participants in total. It began in 2023-05-01 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to explore the safety of laparoscopic resection of 5cm or larger gastric gastrointestinal stromal tumors
Eligibility Criteria
Inclusion Criteria: 1. 18 years \< age \< 75 years 2. Primary gastric lesion diagnosed as gastric GSIT by endoscopic biopsy histopathology or suspected gastric GIST by preoperative endoscopy, ultrasound endoscopy, or CT or MR, and confirmed as primary gastric GIST by postoperative pathology 3. Patient informed consent and willingness to undergo laparoscopic resection 4. Expected laparoscopic outcome of R0 resection 5. Performance status: Eastern Cooperative Oncology Group (ECOG) ≤ 2, Preoperative American Society of Anesthesiologists（ASA） score I-III Exclusion Criteria: 1. Women during pregnancy or breast-feeding 2. Severe mental disorder 3. History of upper abdominal surgery (except the history of laparoscopic cholecystectomy) 4. History of gastric surgery (except ESD/EMR for gastric cancer) 5. History of other malignant diseases within the past five years 6. History of unstable angina or myocardial infarction within the past six months 7. History of a cerebrovascular accident within the past six months 8. History of continuous systematic administration of corticosteroids within one month 9. Requirement of simultaneous surgery for other diseases 10. Emergency surgery due to complications (bleeding, obstruction, or perforation) caused by gastric cancer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05938309 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Gastrointestinal Stromal Tumors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05938309 currently recruiting?
Yes, NCT05938309 is actively recruiting participants. Contact the research team at Pingli811002@163.com for enrollment information.
Where is the NCT05938309 trial being conducted?
This trial is being conducted at Fuzhou, China.
Who is sponsoring the NCT05938309 clinical trial?
NCT05938309 is sponsored by Fujian Medical University. The trial plans to enroll 194 participants.